[English] 日本語
Yorodumi
- PDB-8cn9: Factor VII binding Fab of the bispecific antibody HMB-001 in comp... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 8cn9
TitleFactor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII
Components
  • (Coagulation factor ...) x 2
  • Fab heavy chain
  • Fab light chain
  • Tissue factor
KeywordsBLOOD CLOTTING / Factor VII / Fab / Bispecific Antibody / HMB-001
Function / homology
Function and homology information


activation of plasma proteins involved in acute inflammatory response / activation of blood coagulation via clotting cascade / coagulation factor VIIa / response to Thyroid stimulating hormone / response to astaxanthin / response to thyrotropin-releasing hormone / response to 2,3,7,8-tetrachlorodibenzodioxine / response to genistein / serine-type peptidase complex / response to carbon dioxide ...activation of plasma proteins involved in acute inflammatory response / activation of blood coagulation via clotting cascade / coagulation factor VIIa / response to Thyroid stimulating hormone / response to astaxanthin / response to thyrotropin-releasing hormone / response to 2,3,7,8-tetrachlorodibenzodioxine / response to genistein / serine-type peptidase complex / response to carbon dioxide / response to vitamin K / response to thyroxine / positive regulation of platelet-derived growth factor receptor signaling pathway / positive regulation of leukocyte chemotaxis / NGF-stimulated transcription / response to cholesterol / cytokine receptor activity / response to growth hormone / positive regulation of positive chemotaxis / Extrinsic Pathway of Fibrin Clot Formation / positive regulation of endothelial cell apoptotic process / positive regulation of blood coagulation / positive regulation of TOR signaling / animal organ regeneration / Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus / Gamma-carboxylation of protein precursors / Removal of aminoterminal propeptides from gamma-carboxylated proteins / positive regulation of endothelial cell proliferation / serine-type peptidase activity / BMAL1:CLOCK,NPAS2 activates circadian expression / positive regulation of interleukin-8 production / cytokine-mediated signaling pathway / protein processing / phospholipid binding / Golgi lumen / response to estrogen / circadian rhythm / positive regulation of angiogenesis / blood coagulation / response to estradiol / protease binding / : / vesicle / response to hypoxia / positive regulation of cell migration / endoplasmic reticulum lumen / external side of plasma membrane / signaling receptor binding / serine-type endopeptidase activity / calcium ion binding / positive regulation of gene expression / cell surface / extracellular space / extracellular region / membrane / plasma membrane
Similarity search - Function
Tissue factor / Tissue factor, conserved site / Tissue factor signature. / Interferon/interleukin receptor domain / Interferon-alpha/beta receptor, fibronectin type III / : / Tissue factor / Peptidase S1A, coagulation factor VII/IX/X/C/Z / : / Coagulation factor-like, Gla domain superfamily ...Tissue factor / Tissue factor, conserved site / Tissue factor signature. / Interferon/interleukin receptor domain / Interferon-alpha/beta receptor, fibronectin type III / : / Tissue factor / Peptidase S1A, coagulation factor VII/IX/X/C/Z / : / Coagulation factor-like, Gla domain superfamily / Coagulation Factor Xa inhibitory site / EGF-like domain / EGF-type aspartate/asparagine hydroxylation site / EGF-like calcium-binding, conserved site / Calcium-binding EGF-like domain signature. / Aspartic acid and asparagine hydroxylation site. / EGF-like calcium-binding domain / Calcium-binding EGF-like domain / Vitamin K-dependent carboxylation/gamma-carboxyglutamic (GLA) domain / Gamma-carboxyglutamic acid-rich (GLA) domain / Gamma-carboxyglutamic acid-rich (GLA) domain superfamily / Vitamin K-dependent carboxylation domain. / Gla domain profile. / Domain containing Gla (gamma-carboxyglutamate) residues. / Epidermal growth factor-like domain. / EGF-like domain profile. / EGF-like domain signature 1. / EGF-like domain signature 2. / EGF-like domain / Fibronectin type III / Fibronectin type III superfamily / Serine proteases, trypsin family, histidine active site / Serine proteases, trypsin family, serine active site / Serine proteases, trypsin family, histidine active site. / Peptidase S1A, chymotrypsin family / Serine proteases, trypsin family, serine active site. / Serine proteases, trypsin domain profile. / Trypsin-like serine protease / Serine proteases, trypsin domain / Trypsin / Peptidase S1, PA clan, chymotrypsin-like fold / Immunoglobulin-like fold / Peptidase S1, PA clan
Similarity search - Domain/homology
beta-D-glucopyranose / : / Coagulation factor VII / Tissue factor
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / MOLECULAR REPLACEMENT / Resolution: 3.4 Å
AuthorsSchluckebier, G. / Johansson, E.
Funding support1items
OrganizationGrant numberCountry
Not funded
CitationJournal: Nat Cardiovasc Res / Year: 2024
Title: A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders.
Authors: Gandhi, P.S. / Zivkovic, M. / Ostergaard, H. / Bonde, A.C. / Elm, T. / Lovgreen, M.N. / Schluckebier, G. / Johansson, E. / Olsen, O.H. / Olsen, E.H.N. / de Bus, I.A. / Bloem, K. / Alskar, O. ...Authors: Gandhi, P.S. / Zivkovic, M. / Ostergaard, H. / Bonde, A.C. / Elm, T. / Lovgreen, M.N. / Schluckebier, G. / Johansson, E. / Olsen, O.H. / Olsen, E.H.N. / de Bus, I.A. / Bloem, K. / Alskar, O. / Rea, C.J. / Bjorn, S.E. / Schutgens, R.E. / Sorensen, B. / Urbanus, R.T. / Faber, J.H.
History
DepositionFeb 22, 2023Deposition site: PDBE / Processing site: PDBE
Revision 1.0Dec 27, 2023Provider: repository / Type: Initial release
Revision 1.1Sep 11, 2024Group: Database references / Category: citation / citation_author
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_DOI / _citation.pdbx_database_id_PubMed / _citation.title / _citation.year
Revision 1.2Nov 20, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature / Item: _pdbx_entry_details.has_protein_modification

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Fab light chain
B: Fab heavy chain
C: Coagulation factor VII
D: Coagulation factor VII
E: Tissue factor
F: Fab light chain
G: Fab heavy chain
H: Coagulation factor VII
I: Coagulation factor VII
J: Tissue factor
K: Fab light chain
L: Fab heavy chain
M: Coagulation factor VII
N: Coagulation factor VII
O: Tissue factor
P: Fab light chain
Q: Fab heavy chain
R: Coagulation factor VII
S: Coagulation factor VII
T: Tissue factor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)446,75434
Polymers445,67920
Non-polymers1,07414
Water00
1
A: Fab light chain
B: Fab heavy chain
C: Coagulation factor VII
D: Coagulation factor VII
E: Tissue factor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)111,6808
Polymers111,4205
Non-polymers2603
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
2
F: Fab light chain
G: Fab heavy chain
H: Coagulation factor VII
I: Coagulation factor VII
J: Tissue factor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)111,7209
Polymers111,4205
Non-polymers3004
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
3
K: Fab light chain
L: Fab heavy chain
M: Coagulation factor VII
N: Coagulation factor VII
O: Tissue factor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)111,5408
Polymers111,4205
Non-polymers1203
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
4
P: Fab light chain
Q: Fab heavy chain
R: Coagulation factor VII
S: Coagulation factor VII
T: Tissue factor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)111,8139
Polymers111,4205
Non-polymers3934
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)144.782, 100.794, 181.739
Angle α, β, γ (deg.)90.000, 101.220, 90.000
Int Tables number4
Space group name H-MP1211
Space group name HallP2yb
Symmetry operation#1: x,y,z
#2: -x,y+1/2,-z
Noncrystallographic symmetry (NCS)NCS oper:
IDCodeMatrixVector
1given(-0.999666969866, -0.0148689503937, -0.0210917915953), (-0.0148039230484, 0.99988517992, -0.00323586753636), (0.021137483788, -0.00292254863523, -0.999772306822)-72.7320505951, -26.4516343682, 0.230755181716
2given(0.922788990252, 0.00516209654217, 0.385271115228), (0.00801696034193, -0.999951019683, -0.00580401423669), (0.385222283645, 0.00844458368855, -0.922785176078)-17.5593633856, -29.8908204572, 89.2647321384
3given(-0.923373158697, -0.000459678317079, -0.383903371297), (0.00695055771373, -0.999855392496, -0.0155204330886), (-0.383840721582, -0.016999493864, 0.923242827031)-89.9657202543, -56.5452559461, 89.1425544585
4given(-0.999982179659, 1.26182700489E-5, -0.00596994188384), (2.43540938443E-5, 0.999998067615, -0.00196575015449), (0.00596990554324, -0.00196586051668, -0.999980247615)-72.4369932984, -26.2080388592, -0.0363563323219
5given(0.924358898801, 0.000555103772763, 0.381523679562), (0.000961923967199, -0.999999154019, -0.000875593557598), (0.381522870755, 0.00117635946812, -0.924358650779)-17.7285216948, -29.8328238711, 89.1302614092
6given(-0.926953681679, -0.00905407783575, -0.375066521696), (0.013667135317, -0.999860121159, -0.00964092988597), (-0.374926768096, -0.0140627803575, 0.926947763778)-89.6919572524, -56.3177428109, 89.4746025994
7given(-0.99997154862, 0.00470112216215, -0.00589927127536), (0.00466922970534, 0.999974473718, 0.00540834607803), (0.0059245459845, 0.00538064715044, -0.999967973683)-72.277070308, -26.1250183924, 0.0673726617053
8given(0.920551100833, -0.000271996003906, 0.390622063859), (0.00101873477489, -0.99999468509, -0.00309709073983), (0.390620830135, 0.00324897057022, -0.920545931095)-17.6492962487, -29.8570026961, 89.2011771201
9given(-0.916343110626, -0.010542445927, -0.400255119195), (0.0111027747442, -0.999937939976, 0.000919015146008), (-0.40023996802, -0.00360180923104, 0.916403292754)-90.1049061177, -56.0740428815, 88.9779407689
10given(-0.999989284425, -0.00456209135285, -0.000786357300422), (-0.0045603085642, 0.999987060945, -0.00225422442251), (0.000796631103447, -0.00225061423527, -0.999997150053)-72.4693358926, -26.1799927908, 0.0571141055669
11given(0.921242540622, 0.00226836188061, 0.388982050849), (0.000599188520196, -0.999990085834, 0.00441239237977), (0.388988203319, -0.00383180998673, -0.921234766447)-17.619941808, -29.9004140554, 89.2826380885
12given(-0.90818321058, -0.0109827099009, -0.418428770645), (0.00801708201478, -0.999928744797, 0.00884486990764), (-0.418496096059, 0.00467818457828, 0.908206547088)-90.0265019299, -56.2344089514, 88.50527348
13given(-0.999976133309, -0.00673696094488, 0.00153172118719), (-0.0067447448834, 0.999964070691, -0.00513475833446), (-0.00149707348714, -0.00514496685341, -0.99998564394)-72.4175394593, -26.1018506384, 0.0831921660682
14given(0.929958206439, -0.00377434430007, 0.367645873909), (-0.000314680769937, -0.999955110873, -0.00946980547235), (0.367665112913, 0.00869083222573, -0.92991764914)-16.8764328373, -29.6977448085, 89.2564204435

-
Components

-
Coagulation factor ... , 2 types, 8 molecules CHMRDINS

#3: Protein
Coagulation factor VII / Proconvertin / Serum prothrombin conversion accelerator / SPCA


Mass: 28103.256 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: F7 / Production host: Homo sapiens (human) / References: UniProt: P08709, coagulation factor VIIa
#4: Protein
Coagulation factor VII / Proconvertin / Serum prothrombin conversion accelerator / SPCA


Mass: 11670.991 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: F7 / Production host: Homo sapiens (human) / References: UniProt: P08709, coagulation factor VIIa

-
Antibody , 2 types, 8 molecules AFKPBGLQ

#1: Antibody
Fab light chain


Mass: 23384.982 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)
#2: Antibody
Fab heavy chain


Mass: 23434.117 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)

-
Protein / Sugars , 2 types, 7 molecules EJOT

#5: Protein
Tissue factor / TF / Coagulation factor III / Thromboplastin


Mass: 24826.512 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: F3 / Production host: Homo sapiens (human) / References: UniProt: P13726
#7: Sugar ChemComp-BGC / beta-D-glucopyranose / beta-D-glucose / D-glucose / glucose


Type: D-saccharide, beta linking / Mass: 180.156 Da / Num. of mol.: 3 / Source method: obtained synthetically / Formula: C6H12O6
IdentifierTypeProgram
DGlcpbCONDENSED IUPAC CARBOHYDRATE SYMBOLGMML 1.0
b-D-glucopyranoseCOMMON NAMEGMML 1.0
b-D-GlcpIUPAC CARBOHYDRATE SYMBOLPDB-CARE 1.0
GlcSNFG CARBOHYDRATE SYMBOLGMML 1.0

-
Non-polymers , 2 types, 11 molecules

#6: Chemical
ChemComp-CA / CALCIUM ION


Mass: 40.078 Da / Num. of mol.: 10 / Source method: obtained synthetically / Formula: Ca
#8: Chemical ChemComp-CS / CESIUM ION


Mass: 132.905 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Cs

-
Details

Has ligand of interestN
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.92 Å3/Da / Density % sol: 57.86 %
Crystal growTemperature: 293 K / Method: vapor diffusion, sitting drop / pH: 7.3
Details: 0.15 M Cesium chloride 15% w/v Polyethylene glycol 3,350

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: ROTATING ANODE / Type: RIGAKU FR-X / Wavelength: 1.5418 Å
DetectorType: DECTRIS PILATUS3 R 1M / Detector: PIXEL / Date: May 8, 2018 / Details: na
RadiationMonochromator: Mirror / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.5418 Å / Relative weight: 1
ReflectionResolution: 3.4→48.5 Å / Num. obs: 69059 / % possible obs: 96.3 % / Redundancy: 4.9 % / Biso Wilson estimate: 63.86 Å2 / CC1/2: 0.98 / CC star: 0.995 / Rmerge(I) obs: 0.31 / Rpim(I) all: 0.15 / Rrim(I) all: 0.35 / Net I/σ(I): 3.6
Reflection shellResolution: 3.4→3.522 Å / Redundancy: 3.7 % / Rmerge(I) obs: 1.05 / Mean I/σ(I) obs: 0.86 / Num. unique obs: 6423 / CC1/2: 0.697 / CC star: 0.906 / Rrim(I) all: 1.21 / % possible all: 91.4

-
Processing

Software
NameVersionClassification
PHENIX1.20.1_4487refinement
HKL-3000data collection
XDSdata reduction
XDSdata scaling
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 3.4→48.5 Å / SU ML: 0.6377 / Cross valid method: FREE R-VALUE / σ(F): 1.33 / Phase error: 41.0162
Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
RfactorNum. reflection% reflectionSelection details
Rfree0.3557 3677 2.85 %Random
Rwork0.3032 125179 --
obs0.3047 68416 93.02 %-
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso mean: 64.3 Å2
Refinement stepCycle: LAST / Resolution: 3.4→48.5 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms29476 0 44 0 29520
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.001930191
X-RAY DIFFRACTIONf_angle_d0.494441086
X-RAY DIFFRACTIONf_chiral_restr0.04084646
X-RAY DIFFRACTIONf_plane_restr0.00415257
X-RAY DIFFRACTIONf_dihedral_angle_d3.93844100
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
3.4-3.440.42741210.39324145X-RAY DIFFRACTION81.35
3.44-3.490.42291300.39634624X-RAY DIFFRACTION88.43
3.49-3.540.61961180.47854192X-RAY DIFFRACTION81.46
3.54-3.590.6277910.50943519X-RAY DIFFRACTION67.01
3.59-3.650.46031450.40454685X-RAY DIFFRACTION91.77
3.65-3.710.49521480.41664802X-RAY DIFFRACTION91.85
3.71-3.770.38671370.38994718X-RAY DIFFRACTION91.62
3.77-3.840.43531450.36224918X-RAY DIFFRACTION94.74
3.84-3.920.34721440.32034884X-RAY DIFFRACTION94.67
3.92-40.45121420.3464936X-RAY DIFFRACTION94.42
4-4.080.36981460.31814844X-RAY DIFFRACTION94.06
4.08-4.180.2851440.27464880X-RAY DIFFRACTION94.97
4.18-4.280.32181470.26674879X-RAY DIFFRACTION94.46
4.28-4.40.30671450.26174919X-RAY DIFFRACTION94.62
4.4-4.530.31571510.24914923X-RAY DIFFRACTION94.45
4.53-4.670.27781390.25734835X-RAY DIFFRACTION94.06
4.67-4.840.2771470.24944947X-RAY DIFFRACTION94.98
4.84-5.030.30381460.24454981X-RAY DIFFRACTION95.83
5.04-5.260.31141490.24445060X-RAY DIFFRACTION98.47
5.26-5.540.32681500.27285128X-RAY DIFFRACTION98.91
5.54-5.890.36331500.26955108X-RAY DIFFRACTION98.5
5.89-6.340.34431500.26685117X-RAY DIFFRACTION99.21
6.34-6.980.3241510.29395127X-RAY DIFFRACTION99.06
6.98-7.980.29691490.28545114X-RAY DIFFRACTION98.43
7.98-10.040.29991430.26864953X-RAY DIFFRACTION95.83
10.05-48.50.35681490.28024941X-RAY DIFFRACTION95.57

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more